Diagnosis and treatment of delirium;Diagnose und behandlung des delirs

Praxis

Volumn 91, Issue 11, 2002, Pages 455-463

  Hepp, U ^a  

^a UniversitatsSpital Zurich Psychiatrische Poliklinik   (Switzerland)

Author keywords

Delirium; Diagnosis; Treatment

Indexed keywords

ALCOHOL; AMISULPRIDE; AMPHETAMINE; ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOMETHIAZOLE; COCAINE; HALOPERIDOL; LORAZEPAM; LYSERGIDE; MIANSERIN; NEUROLEPTIC AGENT; OLANZAPINE; OPIATE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEDATIVE AGENT; THIAMINE;

ALCOHOL WITHDRAWAL; CLINICAL FEATURE; DELIRIUM; DEMENTIA; DEPRESSION; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG CHOICE; HUMAN; PATHOGENESIS; PRACTICE GUIDELINE; PRIMARY PREVENTION; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SECONDARY PREVENTION;

EID: 0037070403     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.91.11.455     Document Type: Review

References (63)

1. Bleuler E.: Lehrbuch der Psychiatrie. 15. Auflage, Berlin Heidelberg New York: Springer; 1983.
2. Lipowski Z. J.: Transient cognitive disorders (delirium, acute confusional states) in the elderly. Am J Psychiatry, 140(11), 1426-36, 1983.
3. Dilling H., Mombour W., Schmidt M. H.: WHO-Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F), Klinisch-diagnostische Leitlinien. Huber, Bern-Göttingen-Toronto, 1991.
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Forth Edition. American Psychiatric Association, Washington, D.C., 1994.
5. Rockwood K.: The occurrence and duration of symptoms in elderly patients with delirium. J Gerontol, 48(4), MI62-6, 1993.
6. Levkoff S. E., Evans D. A., Liptzin B., Cleary P. D., Lipsitz L. A., Wetle T. T., Reilly C. H., Pilgrim D. M., Schor J., Rowe J.: Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med, 152(2), 334-40, 1992.
7. Gustafson Y., Brannstrom B., Norberg A., Bucht G., Winblad B.: Underdiagnosis and poor documentation of acute confusional states in elderly hip fracture patients. J Am Geriatr Soc, 39(8), 760-5, 1991.
8. Trzepacz P. T.: A review of delirium assessment instruments. Gen Hosp Psychiatry, 16(6), 397-405, 1994.
9. American Psychiatric Association: Practice guideline for the treatment of patients with delirium. American Psychiatric Association. Am J Psychiatry, 156(5 Suppl), 1-20, 1999.
10. Liptzin B., Levkoff S. E.: An empirical study of delirium subtypes. Br J Psychiatry, 161, 843-5, 1992.
11. Massie M. J., Holland J., Glass E.: Delirium in terminally ill cancer patients. Am J Psychiatry, 140(8), 1048-50, 1983.
12. Levkoff S., Cleary P., Liptzin B., Evans D. A.: Epidemiology of delirium: an overview of research issues and findings. Int Psychogeriatr, 3(2), 149-67, 1991.
13. Trzepacz P. T.: The Delirium Rating Scale. Its use in consultation-liaison research. Psychosomatics, 40(3), 193-204, 1999.
14. Holmes J., House A.: Psychiatric illness predicts poor outcome after surgery for hip fracture: a prospective cohort study. Psychol Med, 30(4), 921-9, 2000.
15. Kelly K. G., Zisselman M., Cutillo-Schmitter T., Reichard R., Payne D., Denman S. J.: Severity and course of delirium in medically hospitalized nursing facility residents. Am J Geriatr Psychiatry, 9(1), 72-7, 2001.
16. Rockwood K., Cosway S., Carver D., Jarrett P., Stadnyk K., Fisk J.: The risk of dementia and death after delirium. Age Ageing, 28(6), 551-6, 1999.
17. Weddington W. W. Jr.: The mortality of delirium: an underappreciated problem? Psychosomatics, 23(12), 1232-5, 1982.
18. Robins P. V., Folstein M. F.: Delirium and dementia: diagnostic criteria and fatality rates. Br J Psychiatry, 140, 149-53, 1982.
19. Franco K., Litaker D., Locala J., Bronson D.: The cost of delirium in the surgical patient. Psychosomatics, 42(1), 68-73, 2001.
20. Marcantonio E. R., Goldman L., Mangione C. M., Ludwig L. E., Muraca B., Haslauer C. M., Donaldson M. C., Whittemore A. D., Sugarbaker D. J., Pass R., et al.: A clinical prediction rule for delirium after elective noncardiac surgery. JAMA, 271(2), 134-9, 1994.
21. Inouye S. K., Rushing J. T., Foreman M. D., Palmer R. M., Pompei P.: Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. J Gen Intern Med, 13(4), 234-42, 1998.
22. Lipowski Z. J.: Delirium (acute confusional states). JAMA, 258(13), 1789-92, 1987.
23. Flacker J. M., Marcantonio E. R.: Delirium in the elderly. Optimal management. Drugs Aging, 13(2), 119-30, 1998.
24. Elie M., Rousseau F., Cole M., Primeau F., McCusker J., Bellavance F.: Prevalence and detection of delirium in elderly emergency department patients. CMAJ, 163(8), 977-81, 2000.
25. Lewis L. M., Miller D. K., Morley J. E., Nork M. J., Lasater L. C.: Unrecognized delirium in ED geriatric patients. Am J Emerg Med, 13(2), 142-5, 1995.
26. Francis J., Kapoor W. N.: Delirium in hospitalized elderly. J Gen Intern Med, 5(1), 65-79, 1990.
27. Passik S. D., Cooper M.: Complicated delirium in a cancer patient successfully treated with olanzapine. J Pain Symptom Manage, 17(3), 219-23, 1999.
28. Trzepacz P. T.: Delirium. Advances in diagnosis, pathophysiology, and treatment. Psychiatr Clin North Am, 19(3), 429-48, 1996.
29. Meagher D. J.: Delirium: optimising management. BMJ, 322, 144-9, 2001.
30. Meagher D. J., Trzepacz P. T.: Moloric subtypes of delirium. Semin Clin Neuropsychiatry, 5(2), 75-85, 2000.
31. Inouye S. K.: Prevention of delirium in hospitalized older patients: risk factors and targeted intervention strategies. Ann Med, 32(4), 257-63, 2000.
32. Breitbart W., Marotta R., Platt M. M., Weisman H., Derevenco M., Grau C., Corbera K., Raymond S., Lund S., Jacobson P.: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry, 153(2), 231-7, 1996.
33. Meagher D. J., O'Hanlon D., O'Mahony E., Casey P. R.: The use of environmental strategies and psychotropic medication in the management of delirium. Br J Psychiatry, 168(4), 512-5, 1996.
34. Tsuang M. M., Lu L. M., Stotsky B. A., Cole J. O.: Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study. J Am Geriatr Soc, 19(7), 593-600, 1971.
35. Smith G. R., Taylor C. W., Linkous P.: Haloperidol versus thioridazine for the treatment of psychogeriatric patients: a double-blind clinical trial. Psychosomatics, 15, 134-138, 1974.
36. Rosen H. S.: Double-blind comparison of haloperidol and thioridazine in geriatric outpatients. J Clin Psychiatry, (40), 17-20, 1979.
37. Thomas IL, Jr., Schwartz E., Petrilli R.: Droperidol versus haloperidol for chemical restraint of agitated and combative patients. Ann Emerg Med, 21(4), 407-13, 1992.
38. Sipahimalani A., Masand P. S.: Olanzapine in the treatment of delirium. Psychosomatics, 39(5), 422-30, 1998.
39. Meagher D. J., O'Hanlon D., O'Mahony E., Casey P. R., Trzepacz P. T.: Relationship between symptoms and motoric subtype of delirium. J Neuropsychiatry Clin Neurosci, 12(1), 51-6, 2000.
40. Platt M. M., Breitbart W., Smith M., Marotta R., Weisman H., Jacobsen P. B.: Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci, 6(1), 66-7, 1994.
41. Ravona-Springer R., Dolberg O. T., Hirschmann S., Grunhaus L.: Delirium in elderly patients treated with risperidone: a report of three cases. J Clin Psychopharmacol, 18(2), 171-2, 1998.
42. Sipahimalani A., Masand P. S.: Use of risperidone in delirium: case reports. Ann Clin Psychiatry, 9(2), 105-7, 1997.
43. Sipahimalani A., Sime R. M., Masand P. S.: Treatment of delirium with risperidone. International Journal of Geriatric Psychopharmacology, 1, 24-26, 1997.
44. Furmaga K. M., DeLeon O. A., Sinha S. B., Jobe T. H., Gaviria M.: Psychosis in medical conditions: response to risperidone. Gen Hosp Psychiatry, 19(3), 223-8, 1997.
45. Uchiyama M., Tanaka K., Isse K., Toru M.: Efficacy of mianserin on symptoms of delirium in the aged: an open trial study. Pros Neuropsychopharmacol Biol Psychiatry, 20(4), 651-6, 1996.
46. Mayo-Smith M. F.: Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA, 278(2), 144-51, 1997.
47. Zilker T.: Alkoholentzugssyndrom und Delirium tremens. Diagnose und Therapie. MMW Fortschr Med, 141(33), 26-30, 1999.
48. Thompson W. L., Johnson A. D., Maddrey W. L.: Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial. Ann Intern Med, 82(2), 175-80, 1975.
49. Athen D., Hippius U., Meyendorf R., Riemer C., Steiner C.: Ein Vergleich der Wirksamkeit von Neuroleptika und Chlormethiazol bei der Behandlung des Alkoholdelirs. Nervenarzt, 48(10), 528-32, 1977.
50. Burroughs A. K., Morgan M. Y., Sherlock S.: Double-blind controlled trial of bromocriptine, chlordiazepoxide and chlormethiazole for alcohol withdrawal symptoms. Alcohol Alcohol, 20(3), 263-71, 1985.
51. Glatt M. M., George H. K., Frisch E. P.: Controlled trial of clormethiazole in treatment of the alcoholic withdrawal phase. BMJ, 2, 401-404, 1965.
52. Majumdar S. K.: Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome. Drug Alcohol Depend, 27(3), 201-7, 1991.
53. McGrath S. D.: A controlled trial of chlormethiazole and chlordiazepoxide in the treatment of the acute withdrawal phase of alcoholism. Br J Addict Alcohol Other Drugs, 70 Suppl I, 81-90, 1975.
54. Caspari D., Wappler M., Bellaire W.: Zur Behandlung des Delirium tremens - ein Vergleich zwischen Clomethiazol und Clorazepat hinsichtlich Effektivität und Nebenwirkungsrate. Psychiatr Prax, 19(1), 23-7, 1992.
55. Athen D.: Comparative investigation of chlormethiazole and neuroleptic agents in the treatment of alcoholic delirium. Acta Psychiatr Scand Suppl, 329, 167-70, 1986.
56. Feuerlein W., Reiser E.: Parameters affecting the course and results of delirium tremens treatment. Acta Psychiatr Scand Suppl, 329, 120-3, 1986.
57. Morgan M. Y.: The management of alcohol withdrawal using chlormethiazole. Alcohol Alcohol, 30(6), 771-4, 1995.
58. Naik P., Lawton J.: Pharmacological management of alcohol withdrawal. Br J Hosp Med, 50(5), 265-9, 1993.
59. Kramp P., Rafaelsen O. J.: Delirium tremens: a double-blind comparison of diazepam and barbital treatment. Acta Psychiatr Scand, 58(2), 174-90, 1978.
60. Saunders J. B., Janca A.: Delirium tremens: its aetiology, natural history and treatment. Current Opinion in Psychiatry, 13, 629-633, 2000.
61. Craft P. P., Foil M. B., Cunningham P. R., Patselas P. C., Long-Snyder B. M., Collier M. S.: Intravenous ethanol for alcohol detoxification in trauma patients. South Med J, 87(1), 47-54, 1994.
62. van Kiel W. A., Havenaar J. M., Klijn F. A., van Dijk A.: Ethanol for treatment of delirium in alcohol dependent patients on intensive care units in the Netherlands: efficacy not proven. Ned Tijdschr Geneeskd, 144(15), 710-3, 2000.
63. Liptzin B.: Delirium. Arch Fam Med, 4(5), 453-8, 1995.